4.20

3.23% -0.14

Unicycive Therapeutics Inc (UNCY)

Overview News Price History Financials Discussions Forecast

Unicycive Therapeutics Inc stock is traded at $4.20, with a volume of 373.07K. It is down -3.23% in the last 24 hours and down -14.29% over the past month. Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

Previous Close:

$4.34

Open:

$4.26

24h Volume:

373.07K

Relative Volume:

0.13

Market Cap:

$53.09M

Revenue:

Net Income/Loss:

$-30.54M

P/E Ratio:

-2.7097

EPS:

-1.55

Net Cash Flow:

$-18.30M

1W Performance:

-13.76%

1M Performance:

-14.29%

6M Performance:

+584.26%

1Y Performance:

+884.30%

1-Day Range:

$4.10

$4.32

1-Week Range:

$4.10

$4.94

52-Week Range:

$0.202

$8.2457

Unicycive Therapeutics Inc Stock (UNCY) Company Profile

Name

Unicycive Therapeutics Inc

Sector

Healthcare (1164)

Industry

Biotechnology (649)

Phone

650-384-0642

Address

4300 EL CAMINO REAL, SUITE 210, LOS ALTOS

Employee

Twitter

Next Earnings Date

2025-03-31

Latest SEC Filings

UNCY's Discussions on Twitter

Compare UNCY with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
UNCY Unicycive Therapeutics Inc	4.20	55.41M	0	-30.54M	-18.30M	-1.55
VRTX Vertex Pharmaceuticals Inc	462.13	117.32B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	558.87	58.89B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	401.80	51.14B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	673.80	41.02B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	299.01	32.59B	3.81B	-644.79M	-669.77M	-6.24

Unicycive Therapeutics Inc Stock (UNCY) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-21-25	Initiated	Guggenheim	Buy
Apr-04-24	Initiated	Piper Sandler	Overweight

Unicycive Therapeutics Inc Stock (UNCY) Latest News

01:54 AM

Real time pattern detection on Unicycive Therapeutics Inc. stockPrice Action Based Buy Zone Forecast - Newser

01:54 AM

12:34 PM

Is it time to cut losses on Unicycive Therapeutics Inc.Weekly Chart-Based Forecast for Traders - Newser

12:34 PM

Aug 01, 2025

Momentum divergence signals in Unicycive Therapeutics Inc. chartExit Strategy Guide With Risk Control Plan - Newser

Aug 01, 2025

Quantitative breakdown of Unicycive Therapeutics Inc. recent moveDaily Investment Ideas with Market Insight - Newser

Aug 01, 2025

Jul 31, 2025

Unicycive Therapeutics Inc. stock trend forecastDaily Upside Movement Prediction With Data - Newser

Jul 31, 2025

How many analysts rate Unicycive Therapeutics Inc. as a “Buy”Best Dividend Tips From AI Tools - jammulinksnews.com

Jul 31, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc.UNCY - PR Newswire

Jul 31, 2025

Does Unicycive Therapeutics Inc. fit your quant trading modelLong Term Equity Screener with Safety Metrics - Newser

Jul 31, 2025

How does Unicycive Therapeutics Inc. compare to its industry peersPre Market Ideas For Beginners - jammulinksnews.com

Jul 31, 2025

Jul 30, 2025

Today's SEC FilingsLatest 10-K, 10-Q, 8-K Forms - Stock Titan

Jul 30, 2025

Real time social sentiment graph for Unicycive Therapeutics Inc.Smart Money Tracking Signal Generator Activated - metal.it

Jul 30, 2025

Unicycive Therapeutics, Inc.'s (NASDAQ:UNCY) Path To Profitability - 富途牛牛

Jul 30, 2025

Unicycive Therapeutics (NASDAQ:UNCY) Trading Down 6.2% – Here’s What Happened - Defense World

Jul 30, 2025

Why Unicycive Therapeutics Inc. stock attracts strong analyst attentionFree Alpha Driven Watchlist With Alerts - Newser

Jul 30, 2025

Evaluating Unicycive Therapeutics Inc. with trendline analysisReal Time Alert System for Market Moves - Newser

Jul 30, 2025

Unicycive Therapeutics Inc. stock trendline breakdownFree Capital Growth With Controlled Risk Picks - Newser

Jul 30, 2025

Jul 29, 2025

What high frequency data says about Unicycive Therapeutics Inc.Price Action Based Buy Zone Forecast - Newser

Jul 29, 2025

Published on: 2025-07-29 22:28:57 - metal.it

Jul 29, 2025

Elliott Wave Theory Predicts Pullback in Unicycive Therapeutics Inc.Low Drawdown Real Time Trading Tips Shared - metal.it

Jul 29, 2025

Published on: 2025-07-29 06:06:35 - Newser

Jul 29, 2025

How Unicycive Therapeutics Inc. stock performs during market volatilityHigh Return Trade Roadmap with Setup Filters - Newser

Jul 29, 2025

Jul 28, 2025

Short Term Charts Align With Long Term Uptrend in Unicycive Therapeutics Inc.Fundamental + Technical Hybrid Stock Tips Shared - beatles.ru

Jul 28, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Unicycive Therapeutics, Inc. (UNCY) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Jul 28, 2025

What are the latest earnings results for Unicycive Therapeutics Inc.Accelerated profit realization - jammulinksnews.com

Jul 28, 2025

When is Unicycive Therapeutics Inc. stock expected to show significant growthTriple-digit wealth increases - jammulinksnews.com

Jul 28, 2025

What are analysts’ price targets for Unicycive Therapeutics Inc. in the next 12 monthsTrack top-performing stocks effortlessly - jammulinksnews.com

Jul 28, 2025

What makes Unicycive Therapeutics Inc. stock price move sharplyUnlock daily market insights for better trades - jammulinksnews.com

Jul 28, 2025

Jul 27, 2025

What is the dividend policy of Unicycive Therapeutics Inc. stockUnlock daily market insights for better trades - jammulinksnews.com

Jul 27, 2025